文献速递系统性红斑狼疮

澳大利亚2010-2022年系统性红斑狼疮患病率:基于关联国家行政健康数据的 population-based 研究

Prevalence of Systemic Lupus Erythematosus in Australia, 2010-2022: A Population-Based Study Using Linked National Administrative Health Data.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2026-04-07

本研究利用澳大利亚国家健康数据中心的关联行政数据,由风湿病学专家组制定算法识别系统性红斑狼疮(SLE)病例并分类为「确定」「不确定」或「无SLE」。共识别26,788例SLE患者(确定16,294例,不确定10,494例),2010-2022年期间患病率为每10万人77至127例(确定病例或总体病例),高于既往澳大利亚报告的19-39/10万,更接近国际估计。

要点

  • 基于关联行政数据识别的SLE期间患病率为77-127/10万,高于既往澳大利亚报告。
  • 确定病例中略超半数仅接受门诊SLE相关照护。
  • 该算法可为未来澳大利亚及国际行政数据SLE识别研究提供基础。

核心结论

  • 澳大利亚2010-2022年SLE期间患病率为每10万人77至127例(确定病例或总体病例),高于既往报告的19-39/10万,更接近国际估计。

研究设计与样本

  • 利用澳大利亚国家健康数据中心的关联国家行政数据(包括药品配发、补贴医疗服务、住院和死亡数据),由风湿病学专家组制定SLE识别算法,将个体分类为「确定」「不确定」或「无SLE」,并计算2010-2022年期间患病率。

主要发现

  • 共识别26,788例SLE个体,其中确定病例16,294例,不确定病例10,494例。
  • 确定病例中略超半数仅接受门诊SLE相关照护。

关键数值与推荐

  • SLE期间患病率(2010-2022年)为每10万人77至127例(确定病例或总体病例)。

临床怎么用

  • 该算法可用于在行政健康数据集中识别SLE,为澳大利亚及国际未来研究提供基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic lupus erythematosus (SLE) is a heterogenous inflammatory condition with widely varying global prevalence estimates. The frequency of SLE in the general population of Australia has been reported to be notably lower than contemporary estimates in countries such as the United States or United Kingdom, at 19 to 39 per 100,000 as opposed to 65 to 97 per 100,000. This study aimed to develop a national SLE cohort using linked administrative data sets and to estimate prevalence using this approach. METHODS: We developed an algorithm to identify SLE cases using the National Health Data Hub, a linked national administrative data asset, which includes data on medications dispensed and medical services subsidized under Australia's universal subsidized coverage schemes, hospital admissions, and deaths. These classification criteria were developed with an expert panel of rheumatologists. Individuals were classified as "certain," "uncertain," or "no SLE." Cohort characteristics were described, and period prevalence (2010-2022) was calculated. RESULTS: A cohort of 26,788 individuals with SLE were identified, which comprised 16,294 certain cases and 10,494 uncertain cases. The period prevalence of SLE in Australia from 2010 to 2022 was 77 to 127 per 100,000 (certain cases or overall cases). Among the certain cases, just over half had received care for SLE only in an outpatient setting. CONCLUSION: This is the first Australian SLE study using comprehensive linked administrative health data, and it identified higher prevalence than previously reported, more closely aligning with international estimates. This algorithm may serve as a foundation for future Australian and international studies seeking to identify SLE in administrative health data sets.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Roper L, Black R, Tieu J, et al. Prevalence of Systemic Lupus Erythematosus in Australia, 2010-2022: A Population-Based Study Using Linked National Administrative Health Data. Arthritis Care Res (Hoboken). 2026. PMID: 41736469. doi:10.1002/acr.80026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。